JAK Kinase Inhibitors
JAK Kinase Inhibitors are a new advanced therapy available in the treatment of a number of forms of arthritis, including rheumatoid arthritis and psoriatic arthritis. Current examples include tofacinitib (Xeljanz), baricitinib (Olumiant), and upadacitinib (Rinvoq).
#rheumatoidarthritis #psoriaticarthritis #ankylosingspondylitis #JAKkinase #arthritistreatment #arthritis